NOVIGENIX
Live / Registered — Registered (as of 03 Feb 2026)
What this means for you
Registered since 03 Feb 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98976186
- Registration number
- 8130190
- Mark type
- Stylized text
- Filed
- 22 Dec 2023
- Published for opposition
- 24 Sept 2024
- Registered
- 03 Feb 2026
- Attorney of record
- Raffi Zerounian
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research services; clinical research in the fields of immunotherapy and drug development; medical and scientific research, namely, conducting, clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; blood analysis services for scientific research purposes
Owner
- Novigenix SA, Epalinges, CH
- Novigenix SA, Epalinges, CH
- Novigenix SA, Epalinges, CH
Prosecution history
- 03 Feb 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Feb 2026 — REGISTERED-PRINCIPAL REGISTER
- 13 Jan 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Jan 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Jan 2026 — ASSIGNED TO EXAMINER
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Jun 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Feb 2025 — USE AMENDMENT FILED
- 25 Jun 2025 — REVIEW OF CORRESPONDENCE COMPLETE
- 25 Jun 2025 — DIVISIONAL PROCESSING COMPLETE
- 03 Feb 2025 — DIVISIONAL REQUEST RECEIVED
- 25 Jun 2025 — SOU EXTENSION 1 GRANTED
- 27 Jan 2025 — SOU EXTENSION 1 FILED
- 18 Jun 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Feb 2025 — TEAS REQUEST TO DIVIDE RECEIVED